<DOC>
	<DOCNO>NCT02122744</DOCNO>
	<brief_summary>Evaluation inhibit rTMS QP visual cortex prevention chronic migraine . The aim study confirm inhibit rTMS QP capable decrease frequency migraine effect strong placebo effect .</brief_summary>
	<brief_title>RCT Versus Placebo rTMSQP Over Visual Cortex Prevention Chronic Migraine</brief_title>
	<detailed_description>The investigator already inquire inhibit rTMS QP visual cortex determines reduction frequency migraine previous study . After 2 weekly session month , investigator demonstrate reduction 47 % migraine frequency . In study , investigator aim compare rTMS QP effect placebo effect evaluate rTMS QP capable induce change VEP , CHEPS QST .</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>diagnosis chronic migraine ( ICHD III beta 1.3 ) without medication overuse . disease contraindication magnetic stimulation ( epilepsy , pacemaker , metallic prothesis )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>